β-amyloid inhibition of long-term potentiation is mediated via tumor necrosis factor

132Citations
Citations of this article
79Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Abstract

A number of recent studies have shown that β-amyloid (Aβ) inhibits the induction of long-term potentiation (LTP) in the hippocampus. However, little is known about the mechanisms underlying such inhibition of LTP. In the present study, we present evidence that the cytokine tumor necrosis factor (TNF) α has a key role in the Aβ inhibition of LTP. The suppression of LTP by Aβ was absent in mutant mice null for TNF receptor type 1 (TNF-R1) and was prevented by the inhibitors of TNFα, infliximab and TNF peptide antagonist, and by the inhibitor of TNFα production, thalidomide. In addition, exogenous TNFα inhibited LTP induction, an action mediated via TNF-R1 as such inhibition was absent in mutant mice null for TNF-R1. The inhibition of LTP by TNFα involved activation of group I metabotropic glutamate receptor and p38 MAP kinase, identical to that for the Aβ-mediated inhibition of LTP induction. © Federation of European Neuroscience Societies.

Cite

CITATION STYLE

APA

Wang, Q., Wu, J., Rowan, M. J., & Anwyl, R. (2005). β-amyloid inhibition of long-term potentiation is mediated via tumor necrosis factor. European Journal of Neuroscience, 22(11), 2827–2832. https://doi.org/10.1111/j.1460-9568.2005.04457.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free